Press Releases
New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year
At DCAT 2024 global bio/pharmaceutical manufacturing forum, Syngene International, a global contract research, development and manufacturing organization (CRDMO), will announce that its newly upgraded biologics facility - Unit 3 - would be operational for clinical and commercial supply in...
Press Releases
CPi Biotech utilises low shear, low pulsation pumps from Watson-Marlow for its bioprocess skids
Peristaltic pumps from Watson-Marlow Fluid Technology Solutions (WMFTS) have been integrated into CPi Biotech’s advanced bioprocess skids
CPi Biotech is using a range of peristaltic pumps from WMFTS for transfer, filling and filtration
Low shear and low pulsation...
Press Releases
Exploring Unlimited Packaging Opportunities at swop 2024: Bringing together the Emerging Forces of the Industry and Driving the New Development of Packaging
With the expansion of the global consumer market and the development of technological updates, the packaging industry has become a major driver of economic growth. The industry is witnessing increased specialization while focusing on intelligence, environmental protection, and sustainability....
Packaging & Labelling
Syntegon launches new SBM Essential Line sterilizers: standardization for shorter delivery times
With the SBM Essential Line, the Syntegon subsidiary Schoeller-Bleckmann Medizintechnik (SBM) launches a new series of its sterilizers, which are based on 50 years of experience. “Thanks to the standardized basis of the SBM Essential Line, pharmaceutical manufacturers benefit...
Drug Research
Elsevier and Iktos partner to deliver an AI-driven synthetic chemistry platform for drug discovery
Elsevier, a global leader in information and data analytics, has signed a multi-year agreement with Iktos, a company specializing in artificial intelligence for new drug discovery. The partnership will strengthen Elsevier's flagship chemistry solution, Reaxys, by combining the company’s...
Drug Research
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
Charles River Laboratories International, Inc. announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on preclinical and early clinical supply of recombinant proteins, providing clients access to Wheeler’s Portable CMC® (Chemistry,...
Drug Research
Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
National Resilience, Inc. (Resilience), Expands Clinical and Commercial Drug Product Manufacturing Capabilities and CapacitiesNational Resilience, Inc. , a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today announced the expansion of the company’s clinical and commercial drug...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.